KR20040047868A - 신규한 제제 및 그의 용도 - Google Patents

신규한 제제 및 그의 용도 Download PDF

Info

Publication number
KR20040047868A
KR20040047868A KR10-2004-7004483A KR20047004483A KR20040047868A KR 20040047868 A KR20040047868 A KR 20040047868A KR 20047004483 A KR20047004483 A KR 20047004483A KR 20040047868 A KR20040047868 A KR 20040047868A
Authority
KR
South Korea
Prior art keywords
nicotine
disease
tobacco
treatment
parkinson
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR10-2004-7004483A
Other languages
English (en)
Korean (ko)
Inventor
토마스 란드
닐스-올로프 린드베르그
Original Assignee
파마시아 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 파마시아 에이비 filed Critical 파마시아 에이비
Publication of KR20040047868A publication Critical patent/KR20040047868A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins or antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Polymers & Plastics (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Physiology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR10-2004-7004483A 2001-09-27 2002-09-10 신규한 제제 및 그의 용도 Ceased KR20040047868A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0103210A SE0103210D0 (sv) 2001-09-27 2001-09-27 New formulations and use thereof
SE0103210-1 2001-09-27
PCT/SE2002/001612 WO2003026656A1 (en) 2001-09-27 2002-09-10 New formulations and use thereof

Publications (1)

Publication Number Publication Date
KR20040047868A true KR20040047868A (ko) 2004-06-05

Family

ID=20285456

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7004483A Ceased KR20040047868A (ko) 2001-09-27 2002-09-10 신규한 제제 및 그의 용도

Country Status (19)

Country Link
EP (1) EP1429770B1 (enrdf_load_stackoverflow)
JP (1) JP4262094B2 (enrdf_load_stackoverflow)
KR (1) KR20040047868A (enrdf_load_stackoverflow)
CN (1) CN1561213A (enrdf_load_stackoverflow)
AR (1) AR036679A1 (enrdf_load_stackoverflow)
AT (1) ATE431144T1 (enrdf_load_stackoverflow)
AU (1) AU2002334523B2 (enrdf_load_stackoverflow)
BR (1) BR0212834A (enrdf_load_stackoverflow)
CA (1) CA2461757C (enrdf_load_stackoverflow)
DE (1) DE60232344D1 (enrdf_load_stackoverflow)
DK (1) DK1429770T3 (enrdf_load_stackoverflow)
ES (1) ES2325684T3 (enrdf_load_stackoverflow)
IL (1) IL160886A0 (enrdf_load_stackoverflow)
MX (1) MXPA04002876A (enrdf_load_stackoverflow)
NZ (1) NZ532528A (enrdf_load_stackoverflow)
RU (1) RU2282447C2 (enrdf_load_stackoverflow)
SE (1) SE0103210D0 (enrdf_load_stackoverflow)
WO (1) WO2003026656A1 (enrdf_load_stackoverflow)
ZA (1) ZA200402091B (enrdf_load_stackoverflow)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
RU2320674C1 (ru) * 2006-07-12 2008-03-27 Каш Тенгис Способ получения сополимера n-винилпирролидона с лаурилметакрилатом для трансдермального введения никотина, сополимер, полученный этим способом, гель для трансдермального введения никотина
CZ200980A3 (cs) * 2009-02-11 2010-04-28 Heglund A.S. Kompozice urcená k bukální absorpci nikotinu za úcelem odvykání kourení
RU2448573C1 (ru) * 2010-12-27 2012-04-27 Олег Иванович Квасенков Способ получения некурительного изделия из махорки
RU2453754C1 (ru) * 2010-12-27 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования Сибирский федеральный университет (СФУ) Устройство для бестраншейной замены трубопроводов

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8404808L (sv) * 1983-10-03 1985-04-04 Avner Rotman Mikrokapslat lekemedel i sot matris
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
SE9803986D0 (sv) * 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
SE0103211D0 (sv) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof

Also Published As

Publication number Publication date
EP1429770B1 (en) 2009-05-13
DE60232344D1 (de) 2009-06-25
EP1429770A1 (en) 2004-06-23
WO2003026656A1 (en) 2003-04-03
DK1429770T3 (da) 2009-08-03
AR036679A1 (es) 2004-09-29
ES2325684T3 (es) 2009-09-14
IL160886A0 (en) 2004-08-31
JP2005503429A (ja) 2005-02-03
RU2004108853A (ru) 2005-04-20
ATE431144T1 (de) 2009-05-15
MXPA04002876A (es) 2005-06-20
CN1561213A (zh) 2005-01-05
JP4262094B2 (ja) 2009-05-13
NZ532528A (en) 2005-10-28
SE0103210D0 (sv) 2001-09-27
AU2002334523B2 (en) 2007-02-15
BR0212834A (pt) 2004-10-13
RU2282447C2 (ru) 2006-08-27
CA2461757C (en) 2008-09-02
ZA200402091B (en) 2005-06-29
CA2461757A1 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
CA2652499C (en) Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
US8470366B2 (en) Nicotine containing soft gelatin pastilles
JP2010006845A (ja) 新規の配合物及びその使用
US20070122457A1 (en) Nicotine and Chocolate Compositions
AU2002334522A1 (en) New formulations and use thereof
EP1429770B1 (en) New formulations and use thereof
AU2002334523A1 (en) New formulations and use thereof
HK1068556A (en) New formulations and use thereof
Allen Formulation of specialty tablets for slow oral dissolution
HK1068555B (en) New formulations and use thereof
JUNO et al. PHARMACEUTICAL SCIENCES
HK1134435A (en) Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20040326

Patent event code: PA01051R01D

Comment text: International Patent Application

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20040330

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20051017

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20060201

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20051017

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I